Lista de obras - Giulia Pasello - Dominio Público Uruguay

18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy

scientific article published on 01 August 2019

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib.

artículo científico publicado en 2016

A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report

artículo científico publicado en 2010

An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

artículo científico

Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

artículo científico publicado en 2015

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

article

COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours.

artículo científico publicado en 2014

Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma.

artículo científico publicado en 2013

Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma.

artículo científico publicado en 2017

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

artículo científico publicado en 2017

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

artículo científico

DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinoma.

artículo científico publicado en 2011

Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?

artículo científico publicado en 2019

Editorial on "The AvaALL Randomized Clinical Trial".

artículo científico publicado en 2019

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.

artículo científico publicado en 2017

Effects of sulfonylureas on tumor growth: a review of the literature

artículo científico publicado en 2013

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

artículo científico publicado en 2019

Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

scientific article published on 06 April 2019

Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy

artículo científico publicado en 2019

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

artículo científico publicado en 2019

Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumab

artículo científico publicado en 2017

LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

artículo científico publicado en 2019

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives

scientific article published on 14 August 2019

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

artículo científico publicado en 2015

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time

artículo científico publicado en 2018

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

artículo científico publicado en 2015

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

artículo científico publicado en 2014

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

artículo científico publicado en 2018

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

artículo científico publicado en 2019

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

artículo científico publicado en 2017

Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience

artículo científico publicado en 2011

Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.

artículo científico publicado en 2009

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

artículo científico publicado en 2014

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

scientific article published on 03 July 2018

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

scientific article published on 21 June 2016

Results of surgical resection after induction chemoradiation for Pancoast tumours †.

artículo científico publicado en 2015

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

artículo científico publicado en 2016

Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma

artículo científico publicado en 2014

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

artículo científico publicado en 2017

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

scientific article published on 01 August 2018

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

artículo científico publicado en 2018

Lista de obras de Giulia Pasello

18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy

A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with Afatinib.

A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report

An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

COPD-related adenocarcinoma presents low aggressiveness morphological and molecular features compared to smoker tumours.

Changes in pulmonary function tests predict radiological response to chemotherapy in malignant pleural mesothelioma.

Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma.

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

DNA copy number profile discriminates between esophageal adenocarcinoma and squamous cell carcinoma and represents an independent prognostic parameter in esophageal adenocarcinoma.

Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?

Editorial on "The AvaALL Randomized Clinical Trial".

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.

Effects of sulfonylureas on tumor growth: a review of the literature

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?

Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumab

LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature

Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience

Preoperative concomitant chemo-radiotherapy in superior sulcus tumour: A mono-institutional experience.

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment

Results of surgical resection after induction chemoradiation for Pancoast tumours †.

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?